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A B S T R A C T
Background: We studied whether the theoretical advantages
of a spring-loaded liver biopsy needle exist in clinical practice
and if so if they are dependent upon the experience of the
physician performing the biopsy.
Methods: In a stratified randomised study we enrolled 215
consecutive patients to compare the safety and efficacy of
a new automatic biopsy gun (Acecut) with that of a standard
Tru-Cut needle.
Results: A total of 464 biopsies were performed. The end-
points of the study were number of needle passes needed
per patient, tissue yield of each needle pass and post-biopsy
complications. The performance of the automatic needle
was superior and more consistent with respect to tissue yield
compared with the Tru-Cut needle (median yield 100%
and 80%, respectively; p<0.001). The difference was most
marked for inexperienced physicians. There was no dif-
ference between the two needles in the number of passes
needed. More post-biopsy pain and post-biopsy use of
analgesics were observed in the automatic needle group
(p=0.04).
Conclusion: The automatic Tru-Cut needle offers an advan-
tage, particularly for physicians with no or limited experience
in liver biopsies. However more post-biopsy pain and post-
biopsy use of analgesics were observed in the automatic
needle group.
I N T R O D U C T I O N
Several new types of automatic spring-loaded Tru-Cut liver
biopsy needles have recently been introduced. These devices
are commonly referred to as ‘biopsy guns’. The potential
advantage of a biopsy gun is the shorter duration of the
actual biopsy procedure which could reduce the number
of complications. In addition, since the difficult Tru-Cut
movement is automated, one would expect the tissue yield
to be larger and needle performance more constant.
However, whether these theoretical benefits are of import-
ance in clinical practice may depend upon the experience
of the physician performing the biopsy.
Aims of the study
We initiated a randomised study of the standard Tru-Cut
liver biopsy needle and an automatic spring-loaded Tru-Cut
device to compare tissue yield, the quality of the biopsy
specimen obtained and post-biopsy complications. A
secondary aim was to test the hypothesis that a possible
advantage of the automated device would be most apparent
among inexperienced operators.
M A T E R I A L S  A N D  M E T H O D S
The study population consisted of a cohort of all consecutive
patients referred for percutaneous liver biopsy to the
Department of Hepatogastroenterology between October
1994 and October 1996. The unit is a tertiary referral centre
for liver diseases and liver transplantation.
Randomisation procedure
A computer-generated randomisation procedure was
followed. Patients were randomly allocated to one of two
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groups using consecutively numbered sealed nonopaque
envelopes. Patients were stratified according to the experi-
ence of the operator. A physician was considered inexperi-
enced if he had performed less than 50 Tru-Cut liver
biopsies.
Biopsy needles
For this study we used a 14 gauge x 11.4 cm Tru-Cut needle
(Baxter Healthcare Corporation, Deerfield, Ill, USA) as
standard needle. This needle has a biopsy specimen notch
of 20 mm. This was compared with a needle biopsy gun
(Acecut, TSK Laboratory, Japan) with a 14 gauge x 11.5 cm
needle and a 15 mm biopsy specimen notch.
Biopsy procedure
Preparation for the biopsy was identical for the two groups.
After informing the patient about the procedure, a mid-
axillary biopsy site was selected and checked by ultrasono-
graphy. The actual biopsy procedure was performed without
ultrasound guidance. If desired by the patient premed-
ication, consisting of intravenous midazolam (Dormicum)
in a bolus dosage of 5 mg, was given. Dosages of 1 to 2.5 mg
were administered to patients over 65 years of age who had
cardiopulmonary or other diseases considered to increase
the risks associated with intravenous administration of
benzodiazepines. Oxygen saturation and heart rate were
monitored by pulse oximetry. After skin disinfection and
liberal local anaesthesia with 1% lidocaine the random-
isation envelope was opened by the endoscopy nurse and
the appropriate biopsy needle was presented. Our standard
procedure is to obtain two biopsy specimens; if the biopsy
was less than 15 mm long, the biopsy pass could be repeated
a maximum of four times.
After the biopsy procedure the wet biopsy specimen was
placed on a plate of paraffin and the length was measured
using a micrometer. All patients undergoing this procedure
as outpatients were observed for three hours in the day-care
facility with standard checks on post-biopsy pain, pulse rate
and blood pressure. A patient with pain was evaluated by
the operator who could prescribe a bolus of 50 or 100 g
intravenous fentanyl citrate (Fentanyl). Our policy is to
administer fentanyl early in the event of post-biopsy pain.
At the end of the three-hour observation period the occur-
rence of pain was scored by the physician as none, mild or
severe. This was further documented by the prescription
of fentanyl. At the end of the three-hour observation period
the patient was again seen by the physician and either sent
home or admitted for further observation. Any admission
was scored as a complication. When an in-patient under-
went the biopsy procedure, the occurrence of pain, use of
fentanyl and complications were recorded by the attending
ward physician the day after the procedure. All data were
registered on standard forms.
Study endpoints
The study endpoints were:
- the number of passes performed and total biopsy
length/number passes;
- the cumulative length of the liver tissue obtained and
the quality of the material obtained (fragmented vs a
coherent biopsy specimen);
- the number of passes with insufficient material defined
as less than 10 mm (insufficient pass), no tissue yield
(failed passes) or no tissue yield at all (failed procedure);
- post-biopsy complications.
Statistical evaluation
The aim was to include at least 50 patients in each physician
stratum. Power calculations were not performed since no
data were available on the performance of the automatic
needle. We assumed that in a study of 100 patients no clin-
ically significant differences would be missed. Since recruit-
ment in the inexperienced physician group was slower than
expected, a total of 215 patients were enrolled. Equality of
the medians was tested by the two-sample Wilcoxon rank-
sum test. The relationship between the type of physician
who took the biopsy, needle type and tissue yield was
evaluated using multiple regression analysis. Whether the
differences between needle types depended on the physician
was tested using appropriate interaction terms. Dichotomous
parameters were tested by Fisher’s exact test.
R E S U L T S
Patients
In total, 215 patients were randomised. Five patients were
excluded from the study because the physician decided
to change the biopsy procedure to either an ultrasound-
guided biopsy (of the left liver lobe) (n=2) or a laparo-
scopic biopsy (n=3). In one case the data sheets were lost.
In total 209 patients could be evaluated. The groups were
well matched for demographic, clinical and laboratory
variables (table 1).
Physicians
Four experienced and three inexperienced physicians par-
ticipated in this study. In 159 cases the biopsy procedure
was performed by an experienced physician (78 automatic
needle and 81 Tru-Cut). In 50 cases the biopsy procedure
was performed by an inexperienced physician (24 automatic
needle and 26 Tru-Cut).
Biopsy length
No differences were found in either the number of passes
needed for each needle type or the number of insufficient
or failed passes. There were no failed procedures.
To correct for the maximum tissue yield possible, all data
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were analysed as percentage of the specimen notch used
per biopsy pass. This percentage was significantly higher
for the automatic needle compared with the Tru-Cut needle
(100 vs 80%; p<0.001) (table 2).
The difference in mean use of the needle notch did not
differ between individual physicians in one group. A clear
trend (p=0.109) was found towards an increased benefit
of the automatic biopsy device among inexperienced
physicians compared with the experienced ones (table 3).
Complications
Three patients (all randomised to the automatic needle
group) suffered complications in this study. Two patients
were admitted because of pain and discharged the next day
without complaints. One patient with documented intraperi-
toneal bleeding received two units of red blood cells. The
difference between the two groups was not statistically
significant.
After a biopsy procedure the pain experienced by the patient
as interpreted by the physician was more severe in the
automatic needle group (p=0.012). This paralleled the
increased prescription of fentanyl in the automatic needle
group (p=0.04). The difference in post-biopsy pain was
independent of the experience of the physician (p=0.08 and
p=0.05 for the experienced and inexperienced groups,
respectively) (table 4).
The overall incidence of major complications in this series
was 0.6% (3/464). The incidence of minor complications
(pain with administration of analgesics) was 13.5% (63/464).
D I S C U S S I O N
When performing a liver biopsy the first decision to be made
is the choice between the cutting needle (Tru-Cut system)
and the aspiration needle (Menghini type). With both needle
types adequate tissue samples can be obtained while there
is an advantage for Tru-Cut needles in diagnosing cirrhosis.1
In an experimental animal model using direct comparison
the Tru-Cut needle performed better compared with aspir-
ation needles with regard to tissue yield and specimen
quality.2 Although the overall incidence of post-biopsy bleed-
ing in nonmalignant liver disease is low (0.4 per 1000 for
fatal bleeding and 1.6 per 1000 for nonfatal bleeding),
the incidence of severe post-biopsy bleeding is higher for
cutting needles compared with aspiration needles.3,4 In the
experimental model as well as in autopsy studies it has been
shown that an automatic biopsy device produces adequate
tissue samples.5 The aim of our study was to compare in
everyday clinical practice the performance of an automatic
with a hand-operated Tru-Cut needle. Our hypothesis was
that the impact of an automatic biopsy device would be the
greatest among inexperienced physicians whereas no clear
advantage would found for experienced physicians. This
study shows that the use of an automatic Tru-Cut needle
device is superior to a standard Tru-Cut needle as far as
tissue yield is concerned. Lindor demonstrated that this is
also true when only experienced operators participate.6
Are these differences clinically relevant? Obviously adequate
tissue specimens can be obtained with both needles. The
tissue yield of the automatic needle seems to be more con-
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Table 1
Patient characteristics and features at entry
AUTOMATIC NEEDLE HAND-OPERATED NEEDLE
Number of patients 102 107
Age 41 (19-72) 45 (17-68)
Sex (female/male) 39/63 38/69
Aetiology of the liver disease
Hepatitis B 47 52
Hepatitis C 24 20
Primary biliary cirrhosis 4 5
Primary sclerosing cholangitis 4 1
Autoimmune hepatitis 2 2




Number of patients with prolonged 1 3 
prothrombin time
APTT (normal 25-40 seconds) 29 (20-40) 28 (23-46)
Platelets (normal 140-360.109/l) 202 (58-660) 202 (41-381)
Bleeding time (normal <240 seconds) 170 (60-355) 142 (60-420)
Continuous data are presented as median plus ranges.
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Table 2
Results of biopsy procedures
AUTOMATIC NEEDLE HAND-OPERATED NEEDLE
Needle passes 2 (1-4) 2 (1-4)
Number of patients (n)
Needle passes (%)
1 pass 5 (4.9) 2 (1.9)
2 passes 77 (75.5) 78 (72.9)
3 passes 17 (16.7) 24 (22.4)
4 passes 3 (2.9) 3 (2.8)
Number of failed needle passes (n)
First biopsy 3 8
Second biopsy 4 7
Third biopsy 0 5
Fourth biopsy 0 0
Number of failed procedures 0 0
(no material obtained)
Biopsy length (mm)
Cumulative biopsy length as percentage of 100 (25-140) 80 (21-138)
biopsy notch (%)
Cumulative biopsy length 30 (15-56) 35 (17-73)
Median biopsy length per pass 15 (5-20) 16 (6-24.5)
Biopsy quality if biopsy obtained
Good-quality first biopsy (%) 94.8 94.8
Good-quality second biopsy (%) 92.3 86.4
Good-quality third biopsy (%) 94.7 85.7
Good-quality fourth biopsy (%) 100 100
Continuous data are presented as median plus ranges. Quality data relate to the percentage of biopsies yielding good quality tissue.
Table 3
Liver tissue yield expressed as percentage of the biopsy notch in relation to the experience of the operator
AUTOMATIC NEEDLE HAND-OPERATED NEEDLE
Inexperienced operator 100% (36-123) 69% (30-137)
Experienced operator 100% (25-140) 85% (21-122)
Data are presented as median plus ranges.
Table 4
Complications and post-biopsy sequelae
NEEDLE TYPE AUTOMATIC NEEDLE HAND-OPERATED NEEDLE
Patients on midazolam pre-medication (%) 82 84
Post-biopsy pain (n (%))
None 45 (47.4) 70 (68.6)
Mild 33 (34.7) 20 (19.6)
Severe 17 (17.9) 12 (11.8)
Post-biopsy fentanyl (n)
None 56 78
50 g 35 17
100 g 4 6
Admissions (n) 3 0
sistent which is particularly beneficial for operators who
perform liver biopsies sporadically. Our data support a
recommendation that those who will not be performing
frequent liver biopsies in the future should learn to use
an automatic device while the type of needle is of less
relevance for those working in specialised liver units.
We started using ultrasound routinely for all patients in
1983. This approach has since been shown to reduce the
incidence of post-biopsy complications.6 However the occur-
rence of post-biopsy pain and use of analgesics were higher
in the automatic needle group. Although it seems logical
to attribute more blunt tissue trauma and more pain to the
spring-loaded device, the study design with regard to the
occurrence of pain should be interpreted with caution:
the scoring of post-biopsy pain and the decision to use
fentanyl were left to the physician in charge and not to more
patient-related measurements. In the combined Mayo Clinic
– Barcelona study 207 patients were biopsied with an auto-
matic Tru-Cut needle under ultrasound guidance and 216
hand-held Tru-Cut biopsies under ultrasound guidance were
performed.6 The occurrence of post-biopsy pain was 40.6%
for the automatic group and 34.3% for the hand-operated
group. The data seem to support the idea that post-biopsy
pain increases with the use of a spring-loaded biopsy
needle. Since compliance with repeated liver biopsies is
essential for the treatment and follow-up of patients with
chronic liver disease, this is an important aspect which
should not be disregarded easily. We can only speculate on
the exact cause of post-biopsy pain with a spring-loaded
biopsy needle. One explanation may be that because some
operators keep close contact with the upper side of the rib
during the procedure, the spring-loaded device causes more
blunt trauma to the periostium.
Our data support the recommendation that physicians who
perform liver biopsies infrequently should learn to use an
automatic Tru-Cut biopsy device. A follow-up study with a
20 mm specimen Tru-Cut biopsy device would be worth-
while, especially to address the issue of an increase in post-
biopsy pain following the use of a spring-loaded biopsy gun.
A C K N O W L E D G E M E N T S
We acknowledge the participation of internists and gastro-
enterologists (in training).
R E F E R E N C E S
1. Vargas-Tank L, Martinez V, Jiron M, Soto JR, Armas-Merino R. Tru-Cut
and Menghini needles: different yield in the histological diagnosis of liver
disease. Liver 1985;5:178-81.
2. Hopper KD, Baird DE, Reddy VV, et al. Efficacy of automated biopsy guns
versus conventional biopsy needles in the pygmy pig. Radiology
1990;176:671-6.
3. McGill DN, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with
major haemorrhage after percutaneous liver biopsy. Gastroenterology
1990;99:1396-400.
4. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following
percutaneous liver biopsy. A multicentre retrospective study on 68 276
biopsies. J Hepatol 1986;2:165-73.
5. Hoper KD, Abendroth CS, Sturtz KW, Matthews YL, Stevens LA, Shirk SJ.
Automated biopsy devices: a blinded evaluation. Radiology 1993;187:653-60.
6. Lindor KD, Bru C, Jorgensen RA, et al. The role of ultrasonography and
automatic-needle biopsy in outpatient percutaneous liver biopsy.
Hepatology 1996;23:1079-83.
D E C E M B E R  2 0 0 4 ,  V O L .  6 2 ,  N O .  1 1
De Man, et al. Automated Tru-Cut needle for liver biopsy.
445
